Hemas Holdings Ltd. · CSELK:HHL.N0000

Hemas — Q3 FY2021-22 Earnings Presentation

36 slides from Hemas's earnings presentation, February 2022

  1. Slide 1: Hemas Holdings PLC Investor Presentation

    Hemas Holdings PLC Investor Presentation First Nine Months ending December 31, 2021 – Q3 FY 2021-22 COPYRIGHT © 2022 | HEMAS HOLDINGS PLC

  2. Slide 2: Our Portfolio

    Our Portfolio Consumer Brands Healthcare Mobility • Home and Personal Care - • Pharmaceutical Import, • Maritime Sri Lanka (HPC SL) Marketing and Distribution • Logistics • Home and Personal Care - • Pharmaceutical Manufacturing - • Aviation International (HPC Int) Morison • Learning Segment - Atlas

  3. Slide 3: Macroeconomic Snapshot of Sri Lanka

    Macroeconomic Snapshot of Sri Lanka Inflation LKR Depreciation Interest Rate GDP Colombo Consumer Price Index (CCPI) After a three-month downward trend, AWPLR is continuously on the rise with the GDP for Q2 2021 picked up 12% YoY reached a record high of 12.1% YoY in official reserves were reported

  4. Slide 4: Macroeconomic Snapshot Continued

    Macroeconomic Snapshot Continued.. Commodity Price Hike COVID-19 Update Pandemic Driven Volatility GSCI Commodity Index Total confirmed cases Supply chain 600 557.4 561.7 536.9 Global economic 613,478 disruptions 550 recovery and supply 500 466.2 disruptions 37 % YoY Continuously 450 409.3 (includin

  5. Slide 5: Our Strategic Building Blocks – Q3 FY 2021-22

    Our Strategic Building Blocks – Q3 FY 2021-22 MORE FROM THE CORE NEW WITHIN THE CORE DRIVERS Accelerate current business efforts to drive Capturing new revenue streams to further higher value in core business strengthen the core Create sustainable • HPC SL : Launched floral variants of washing powde

  6. Slide 6: Financial Snapshot of the Group

    Financial Snapshot of the Group YTD FY 2021-22 Group Revenue by Segment EBIT by Segment YTD FY 2021-22 YTD FY 2021-22 (LKR Mn) LKR 57.7Bn LKR 5.34 0.0% 6,500 5,254 (0.1%) 20.5% 33.2% 2.7% 4,743 (3.0%) 5,500 4,286 1,057 399 Revenue EPS 621 4,500 2,576 39.0% 256 2,186 (40.1%) 3,500 2,607 2,775 LKR 5.3

  7. Slide 7: Sector Performance Summary – YTD FY 2021-22

    Sector Performance Summary – YTD FY 2021-22 Revenue Walk EBIT Walk (LKR Mn) (LKR Mn) -202 -420 658 476 5,254 3,270 128 -32 57,722 4,743 6,446 47,910 YTD 2021 Healthcare Consumer Mobility Other YTD 2022 YTD FY 21 Healthcare Consumer Mobility Other YTD FY22 Note: The ‘other segment’ includes the corpo

  8. Slide 8: Sector Performance Summary – Q3 FY 2021-22

    Sector Performance Summary – Q3 FY 2021-22 Revenue Walk EBIT Walk (LKR Mn) (LKR Mn) 1,764 -95 -13 21,545 441 66 2,616 2,212 229 -216 17,676 2,095 Q3 FY21 Helathcare Consumer Mobility Other Q3 FY22 Q3 FY21 Healthcare Consumer Mobility Other Q3 FY22 Note: The ‘other segment’ includes the corporate off

  9. Slide 9: Continuing Operation EPS

    Continuing Operation EPS EPS Walk (LKR Per Share) -0.59 0.86 0.21 6.00 -0.15 5.34 5.02 5.00 4.00 3.00 2.00 1.00 0.00 YTD FY21 Operating Profit Net Finance Cost Income Tax NCI YTD FY22 COPYRIGHT © 2022 | HEMAS HOLDINGS PLC 9

  10. Slide 10: Capital Employed

    Capital Employed – YTD FY 2020-21 Sector Efficiency Capital Employed, ROCE, and EBIT by Sector 50% 40% Mobility Consumer Healthcare LKR 707.0 Mn LKR 2,186.3 Mn LKR 2,716.4 Mn 30% 20% Group ROCE – 17.6% ROCE (%) 10% 0% 0 5 10 15 20 25 Capital Employed (LKR Bn) -10% Other -20% LKR (705.2 Mn) -30% Note

  11. Slide 11: Consumer Brands

    Consumer Brands Home and personal care – Sri-Lanka Home and personal care – International Learning Segment COPYRIGHT © 2022 | HEMAS HOLDINGS PLC 11

  12. Slide 12: Consumer Brands

    Consumer Brands Contribution to Group Sector Performance – Q3 FY 2021-22 Revenue % 45% Key Highlights Revenue (LKR Mn) 22.2% 45% (YoY) • The pandemic continued to influence 9,698 consumer behaviour, sales mix and 9,000 market channels. 7,933 Q3FY22 7,327 5,827 • Resulting from lower infection rates,

  13. Slide 13: Home and Personal Care – Sri Lanka

    Home and Personal Care – Sri Lanka Key categories with market Purpose-driven brands touching the lives of the Sri Lankan consumer 8 leading positions Entered the ‘Salon Channel’ with ‘Swa’ Inclusive Strong roots Parenting Stronger Make a Celebrating & Enabling Both parents together Positive Differen

  14. Slide 14: Home and Personal Care Sri Lanka: Strong Brand Portfolio

    Home and Personal Care Sri Lanka: Strong Brand Portfolio of business where Hemas is 95% among the Top 3 players #1 #1 #1 #2 Presence in all modern In Hair Oil In Beauty Soap In Baby Care In Feminine Care trade chains and outlets of households reached by 98% Hemas brand #2 #2 In Laundry Care In Oral

  15. Slide 15: Our Consumer Health Brands

    Our Consumer Health Brands Skincare Baby Care Cold and Flu COPYRIGHT © 2022 | HEMAS HOLDINGS PLC 15

  16. Slide 16: Home and Personal Care – International

    Home and Personal Care – International Locally led and localized in Bangladesh Reach in Bangladesh 2 Geographies Bangladesh & West Bengal • All products are exclusively designed for Bangladesh. Rural penetration 19.0% by Hemas • We have a local leadership team with 90% 2 Key categories Health soap c

  17. Slide 17: Home and Personal Care – Sri Lanka and International

    Home and Personal Care – Sri Lanka and International Sri Lanka International Revenue (LKR Mn) Revenue 17.6% Revenue • Increased market shares in the larger Personal Care (YoY) • HPC Bangladesh witnessed double digit revenue space such as hair and toothpaste. 6,000 5,625 5,102 growth whilst profitabi

  18. Slide 18: Learning Segment

    Learning Segment Revenue 6 Key categories • Atlas continued to gain market share across all key categories including books and colour products over last year. Revenue (LKR Mn) 29.2% (YoY) • Market share within the premium books category was doubled with the relaunch of the Innovate High Efficiency a

  19. Slide 19: Atlas: Where We Inspire the Next Generation to Unleash Their Potential

    Atlas: Where We Inspire the Next Generation to Unleash Their Potential “We provide tools, content and experiences which will enable the next generation to unleash their potential” Carefully Crafted Brand Portfolio Atlas KIDS in Line with Growth Areas Catering to all stationery and back to school • O

  20. Slide 20: New Product Launches during the Quarter

    New Product Launches during the Quarter Home and Personal Care Home and Personal Care Learning Segment Sri Lanka International Expanding the Baby Cheramy Portfolio Expanding the Actisef Nourish innovate brand New themes under Atlas Brand Floral Baby Laundry wash Newborn Baby Powder and Liquid Diaper

  21. Slide 21: Healthcare Sector

    Healthcare Sector Pharmaceutical Import, Marketing and Distribution Pharmaceutical Manufacturing Hospitals COPYRIGHT © 2022 | HEMAS HOLDINGS PLC 21

  22. Slide 22: Healthcare Sector

    Healthcare Sector Contribution to Group Sector Performance – Q3 FY 2021-22 Revenue % 53% Key Highlights Revenue (LKR Mn) 23.9% • Market demand for healthcare services 52% (YoY) and medicines experienced a sudden 12,000 11,847 11,477 surge with the COVID cases escalating. 10,021 10,339 • Hospitals re

  23. Slide 23: Pharmaceutical Import, Marketing, Distribution and Manufacturing

    Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Pharmaceutical Import, Marketing, and Pharmaceutical Manufacturing Morison Plant and Key Highlights Distribution NPD focused separate manufacturing Principals Formulations - Manufacturing line consisting of advanced tech

  24. Slide 24: Pharmaceutical Import, Marketing, Distribution and Manufacturing

    Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Revenue • The distribution segment witnessed a double digit growth in revenue owing to steady demand. Revenue (LKR Mn) • Manufacturing segment revenue was adversely impacted by the slowdown in government buy-back revenue

  25. Slide 25: Hospitals

    Hospitals Revenue • Witnessed an average increase in admission 180+ Beds volumes by 25 % over last year. • Focus on non-COVID-19 patients was increased, Revenue (LKR Mn) especially Non Communicable Diseases (NCDs) which translated to elective surgeries. 2,000 59% Hospital occupancy 1,770 45.9% (YoY)

  26. Slide 26: We are the only COVID-Certified Hospital in Sri Lanka

    We are the only COVID-Certified Hospital in Sri Lanka Hemas Hospitals Highlights Centers of Excellence: “The first Internationally accredited hospitals chain in Sri Lanka by the Australian • In vitro fertilization unit (IVF) (50 cycles in Council on Healthcare Standards International (ACHSI)” Oct-De

  27. Slide 27: We have a widespread Lab Network

    We have a widespread Lab Network 50+ Labs & Collection Centers Lab Network Highlights Q3 FY 2021-22 Performance across the Country Centers of Excellence: • Main Lab Services to Hospitals (10 279k+ B2B Labs +4 B2B CCs) Test volumes • Outer Labs services across the country (14 Labs) 605+ • Collection

  28. Slide 28: Mobility Sector

    Mobility Sector Maritime Logistics Aviation COPYRIGHT © 2022 | HEMAS HOLDINGS PLC 28

  29. Slide 29: Mobility Sector

    Mobility Sector Contribution to Group Sector Performance – Q3 FY 2021-22 2% Revenue % Key Highlights Revenue (LKR Mn) 3% • Growth in industry freight rates partially 1,000 20.8% negated the adverse impact of the drop in 734 (YoY) throughput, due to vessels continuing to Q3FY22 587 595 skip Colombo t

  30. Slide 30: Mobility Sector

    Mobility Sector 2Far Shipping line – Evergreen line & Far Shipping “Offering a Full Spectrum of End-to-end Services across Land, Sea and Air” 125,000+ TEUs Emirates Sky Cargo – 1st in the network to Represents the leading Throughput Facilitating over 1000+ feeder operator to the operate mini freight

  31. Slide 31: Group Digital Transformation

    A Group Digital Transformation that will Reimagine, Re-organize, Rebuild, Reinvent and Refocus Hemas Digital Outcomes Reorganize Leadership, Organization & Governance Revenue and Value Creation New Ways of Working Skills for the future New digital Customer Digital DNA in our people Predictive data /

  32. Slide 32: Environmental Agenda 2030

    Environmental Agenda 2030 Responsible Plastic Manufacture Safeguard our Eco System Protect our Natural Resources and Disposal Practices We will embrace and Actively pursue the use of From Design to disposal, natural resources in a we will strive to reduce use champion initiatives that responsible ma

  33. Slide 33: Social and Purpose Led Initiatives

    Social and Purpose Led Initiatives Say Yes To Life Eka Se Salakamu Sonduru Diriyawanthi Providing natural hair wigs Creating a social movement Create awareness and support to patients undergoing to empower children and the early management of chemotherapy and families with Downs diabetes in our comm

  34. Slide 34: Sustainability Performance – Q3 FY 2021-22 vs Q3 FY 2020-21

    Sustainability Performance – Q3 FY 2021-22 vs Q3 FY 2020-21 Values of Fines for Non-Compliance Carbon Footprint (per Rs. Mn Revenue) 0.21 MT 12% with Laws and Regulations in the NONE Social Economic Area Water Consumption Total Work-Related Injury Rate (per Rs. Mn Revenue) 252.9 m3 4% (per 100 emplo

  35. Slide 35: Corporate Governance

    Corporate Governance COG Group CEO COG Consists of the senior leadership team of 9 members - MDs of our 5 major businesses and 4 leaders from Corporate Nomination & Office. Responsible for formulation and implementation of Group strategic plan. The COG, as in a gearbox in a Group Audit Governance ve

  36. Slide 36: Disclaimer

    Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this

Hemas Holdings — Q3 FY2021-22 Earnings Presentation on 6ix